Skip to content

Study of the effective volume and anesthetic effect of hydromorphone combined with ropivacaine in ultrasound-guided supraclavicular brachial plexus

Study of the effective volume and anesthetic effect of hydromorphone combined with ropivacaine in ultrasound-guided supraclavicular brachial plexus

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094803
Enrollment
Unknown
Registered
2024-12-27
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb injury

Interventions

Adjuvant group:0.3% ropivacaine combined with hydromorphone 1 mg

Sponsors

Yan 'an Hospital of Kunming City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Study subjects and family members shall sign an informed consent to anesthesia. (2) Patients with an ASA grade I-III, regardless of gender, aged 18-75 years, who intend to undergo elective upper limb surgery on the elbow, forearm, and hand. (3) There were no serious complications and all patients underwent complete preoperative preparation, including complete preoperative tests: blood routine, clotting function, four tests before transfusion, liver and kidney function, electrolytes, blood sugar, blood lipids, chest plates, electrocardiogram, etc. (4) Fasting time >= 6 hours, liquid-fasting time >= 2 hours.

Exclusion criteria

Exclusion criteria: (1) Past allergies to research drugs occur. (2) Patients with clotting dysfunction, neuromuscular disease, severe systemic infection or infection at the puncture site. (3) People with moderate to severe heart, lung or liver and kidney disease, cerebrovascular disease, malignant conduction blockage, or sinus tachycardia; People who use high doses of sedation and pain medication for a long time; Persons with a history of mental illness who cannot cooperate; A person who is a plegic is rejected. (4) Women in pregnancy.

Design outcomes

Primary

MeasureTime frame
Onset time of sensory block;Onset time of motor block;Duration of sensory block;Duration of motor block;Evaluation standard of brachial plexus block effect;

Secondary

MeasureTime frame
VAS score;Evaluation of recovery quality of patients;Incidence of postoperative rebound pain;Incidence of tourniquet pain;

Countries

China

Contacts

Public ContactFurong Zhang

Yan 'an Hospital of Kunming City

1742110419@qq.com+86 184 6914 5684

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026